Abstract
Metagenomic methods for IE detection can provide clinicians with valuable information to diagnose and treat IE patients after valve replacement surgery. However, more efforts should be made to optimize protocols for sample processing, sequencing and bioinformatics analysis.
Introduction
Infective endocarditis (IE) remains a life-threatening condition characterized by infection of the heart valves. Despite advancements in medical care, the "gold standard" for diagnosis—microbiological culture—frequently fails. Approximately 31% of IE cases are classified as culture-negative, often due to prior antibiotic administration or the presence of fastidious organisms that do not grow under standard laboratory conditions.
While targeted 16S rRNA sequencing is sometimes employed, it is restricted to bacterial detection and lacks the ability to identify antimicrobial resistance (AMR) markers. This study investigates the utility of metagenomic shotgun sequencing to identify pathogens and their resistance profiles directly from resected heart valve tissue, bypassing the limitations of traditional culture-based methods.
Methodology
The study analyzed resected heart valve samples from seven patients clinically diagnosed with IE at Fuwai Hospital, China, whose cultures were negative. The research compared two primary sequencing platforms:
- Next-Generation Sequencing (NGS): Utilizing the BGISEQ-500 platform for high-accuracy, short-read data.
- Nanopore Sequencing: Utilizing the Oxford Nanopore MinION for real-time, long-read analysis.
The bioinformatics pipeline involved several critical steps:
- Host Depletion: Using the Burrows-Wheeler Aligner (BWA) to filter out human DNA, which typically constitutes over 95% of the sample.
- Pathogen Identification: Aligning remaining reads against a comprehensive microbial database using the Centrifuge k-mer alignment algorithm.
- AMR Detection: Mapping sequences against the Comprehensive Antibiotic Resistance Database (CARD) to identify resistance genes.
Results
Metagenomic analysis achieved a 100% detection rate, successfully identifying the causative pathogen in all seven culture-negative cases. Identified organisms included Streptococcus gordonii, S. oralis, S. sanguinis, S. anginosus, and difficult-to-culture pathogens such as Coxiella burnetii and Bartonella quintana.
Key findings include:
- Enhanced Resolution: Metagenomics provided species-level identification where traditional Sanger sequencing often only reached the genus level.
- Rapid Diagnostics: The Nanopore platform demonstrated the potential for "point-of-care" use, identifying pathogens within one hour of sequencing.
- AMR Profiling: Resistance genes, such as tetM (tetracycline) and ErmB (macrolides), were identified. NGS detected a broader range of AMR features due to higher data throughput (46 Gb vs. 15 Gb for Nanopore).
Discussion
The study highlights the "host DNA bottleneck," where the vast majority of sequencing data is consumed by the human genome rather than the pathogen. This emphasizes the need for improved host-depletion techniques to increase sensitivity and reduce costs. Furthermore, while Nanopore sequencing offers speed, issues like "barcode leaking" in multiplexed runs suggest that clinical applications might require running single samples per flow cell to ensure diagnostic accuracy.
Conclusion
Metagenomic sequencing, particularly when combining the accuracy of NGS with the speed of Nanopore platforms, represents a transformative tool for diagnosing culture-negative IE. By providing rapid species-level identification and AMR profiles, these methods offer a pathway toward more precise and timely clinical interventions for patients with life-threatening heart infections.
Summary updated